This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
New deal is $1.4bn higher than previous one struck down by Supreme Court last year
US president threatens to double tax rates for foreign nationals and companies
People treated with amycretin lost up to 22% of their body weight after 36 weeks
FTSE’s most valuable company faces potential fine over suspected unpaid taxes in...
Shares rebound after disappointing sales of blockbuster medications last year le...
Drugmaker pins hopes on launch of new medicines but key point is to avoid re-tra...
How an agreement set up by the Tories and lauded by Labour fell victim to cost-c...
Efficacy of the drugs has driven their success, but the potential side-effects p...
Private equity firm expects $3.3bn acquisition of Tanabe will get boost from eas...
Founder of Isomorphic Labs aims to develop a drug in oncology, cardiovascular or...
Pharma groups say higher levy will stifle growth of life sciences
Anaesthetics are not putting patients to sleep, doctors warn, in call for greate...
Panel grills Donald Trump’s nominee for top health post on abortion stance and ‘...
Decision is a blow to Starmer’s government after setting out pro-growth pitch to...
UK company raised NHS rejection of its new breast cancer drug and drug pricing m...
Drugmaker pauses Gardasil exports to help ‘trusted partner’ reduce excess inventory
Albert Bourla says Donald Trump’s nominee for health secretary still appeared to...
UK pharma group raises long-term annual sales forecast to more than £40bn by 2031
Western drugmakers look to Chinese trials for early data on treatments’ potentia...